Insight Molecular Diagnostics (IMDX) Assets Growth (5y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) Assets Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 170.35 Mn | 141.42 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.75% |
| Dec 31, 2025 | -14.21% |
| Sep 30, 2025 | -5.33% |
| Jun 30, 2025 | -4.46% |
| Mar 31, 2025 | 0.29% |
| Dec 31, 2024 | -2.52% |
| Sep 30, 2024 | 16.46% |
| Jun 30, 2024 | 14.68% |
| Mar 31, 2024 | 11.23% |
| Dec 31, 2023 | 51.07% |
| Sep 30, 2023 | 44.60% |
| Jun 30, 2023 | 48.32% |
| Mar 31, 2023 | 39.66% |
| Dec 31, 2022 | 57.84% |
| Sep 30, 2022 | 61.66% |
| Jun 30, 2022 | 69.74% |
| Mar 31, 2022 | 57.33% |
| Dec 31, 2021 | 61.67% |
| Sep 30, 2021 | 58.44% |
| Jun 30, 2021 | 88.65% |